Myosin Inhibition and Left Ventricular Diastolic Function in Patients with Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Insights from the VALOR-HCM Study

Milind Y. Desai

Department of Cardiovascular Medicine, Cleveland Clinic Coordinating Center for Clinical Research Heart Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH; Hypertrophic Cardiomyopathy Center, Cleveland Clinic, Cleveland, OH